Skip to content
Screener

Bioventus BVS International Segment — Adjusted selling expense

Similar metrics at other companies

Hillman Solutions Corp. logo
HLMNCanada — Adjusted selling expense
$3.66M+14.3%
Hillman Solutions Corp. logo
HLMNHardware and Protective Solutions — Adjusted selling expense
$30.3M+4.8%
Hillman Solutions Corp. logo
HLMNRobotics and Digital Solutions — Adjusted selling expense
$19.39M+17.3%
Primo Brands logo
PRMBReportable Segment — Selling expense, adjusted
$119.4M+1.9%
Hain Celestial Group logo
HAINInternational — Adjusted Selling General And Administrative Expenses
-$17.6M-17.5%
The Clorox Company logo
CLXInternational — Segment Adjusted EBIT
$27M+17.4%

Other financials

Income statement

See full
Revenue$153.2M+3.8%
Gross profit$105.7M+3.5%
Operating income$19.1M+4.1%
Net income$33.4M+348%
EPS (diluted)$0.47+327%

Balance sheet

See full
Cash & equivalents$29.5M-10.5%
Total debt$263.7M-26.9%
Total equity$228.3M+41.6%
Total assets$673.3M-4.7%

Cash flow

See full
Operating cash flow$19.9M-23.4%
CapEx$960.0K+40.6%
Free cash flow$18.9M-25.1%

Valuation

See full
Market cap$1.19B+156%
Enterprise value$1.42B+79.7%
P/E21.8×
P/S+1.2×

Profitability

See full
Gross margin68.7%+1.1pp
Operating margin10%
Net margin9.4%+9.2pp
FCF margin16.2%+10.2pp

Returns & leverage

See full
Return on equity28%+27.5pp
Debt / equity1.2×-1.1×
Current ratio1.7×+0.2×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept bvs:SellingExpenseAdjusted.

The source filing: Bioventus’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 7:43 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001665988-26-000042

FAQ

What is Bioventus's international segment — adjusted selling expense?
Bioventus (BVS) reported international segment — adjusted selling expense of $3.39M in Q2 2026.
How has Bioventus's international segment — adjusted selling expense changed year-over-year?
Bioventus's international segment — adjusted selling expense increased by 5.3% year-over-year, from $3.22M to $3.39M.
What is the long-term trend for Bioventus's international segment — adjusted selling expense?
Over 3 years (2022 to 2025), Bioventus's international segment — adjusted selling expense has grown at a 4.0% compound annual growth rate (CAGR), from $11.29M to $12.69M.
What does international segment — adjusted selling expense mean?
Captures the adjusted costs incurred by the sales force and distribution teams dedicated to the international segment. It provides insight into the investment required to maintain and expand market share in foreign territories.

Ask your AI about Bioventus's international segment — adjusted selling expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude